Medco Health Unit Settles Overbilling Suit For $5.3M
Accredo Health Group, which Medco acquired in 2005, reached the settlement in January, according to a filing with the U.S. Securities and Exchange Commission.
The allegations of overbilling and making false claims arose in conjunction with a joint venture controlled by Accredo.
The company, in which Accredo had an 80% stake, provided a blood-clotting product to a California pharmacy. The pharmacy’s billings to MediCal for...
To view the full article, register now.